Humacyte, Inc.
HUMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001818382
In the last 90 days, Humacyte, Inc. insiders filed 3 open-market purchases and 0 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $57.3M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Humacyte, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 78 | 2 | 70 | −6 |
| Shares | 13.4M | 17.1K | 11.8M | −1.58M (−11.8%) |
| Value | $43.1M | $55.0K | $38.6M | −$4.47M (−10.4%) |
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Humacyte, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Hamilton Lane Advisors LLC | 52,693 | $172.0K | 0.06% |
| Simplex Trading, LLC | 40,725 | $132.0K | 0.01% |
| Ergoteles LLC | 31,276 | $102.0K | 0.00% |
| Teacher Retirement System of Texas | 18,343 | $60.0K | 0.00% |
| SG Americas Securities, LLC | 10,826 | $35.0K | 0.00% |
| Virginia Retirement Systems Et Al | 10,600 | $34.6K | 0.00% |
| China Universal Asset Management Co., Ltd. | 965 | $3.00K | 0.00% |
| Wipfli Financial Advisors LLC, | 200 | $1.00K | 0.00% |
Sold out (14)
Institutions that held Humacyte, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| HRT Financial LP | 58,632 | $188.0K |
| CenterBook Partners LP | 41,470 | $133.0K |
| Josh Arnold Investment Consultant, LLC | 22,000 | $71.0K |
| Cubist Systematic Strategies, LLC | 19,500 | $63.0K |
| Jane Street Group, LLC | 19,040 | $61.0K |
| AQR Capital Management LLC | 18,366 | $59.0K |
| UBS Asset Management Americas Inc | 15,947 | $51.2K |
| Jump Financial, LLC | 15,100 | $48.0K |
| Powell Investment Advisors, LLC | 14,000 | $45.0K |
| Kovitz Investment Group Partners, LLC | 11,550 | $37.0K |
| Parallax Volatility Advisers, L.P. | 7,500 | $24.0K |
| STRS Ohio | 4,100 | $13.0K |
| Penserra Capital Management LLC | 2,712 | $8.00K |
| Point72 Hong Kong Ltd | 1,395 | $4.00K |
Not filed for Q3 2022 yet (2)
Institutions that held Humacyte, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Exos Asset Management LLC | 17,084 | $55.0K |
| Urban Wealth Management, LLC | 11 | $0 |